Fujimoto, Daichi <br/><br/>
Programmed Cell Death Ligand 1 Expression in Non-Small-cell Lung Cancer Patients With Interstitial Lung Disease: A Matched Case-control Study.  [electronic resource] 

 -  Clinical lung cancer  09 2018 
 - e667-e673 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1938-0690 
<br/><br/><label>Standard No.: </label>10.1016/j.cllc.2018.04.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Aged<br/>Antineoplastic Agents, Immunological--therapeutic use<br/>B7-H1 Antigen--antagonists & inhibitors<br/>Biomarkers, Tumor--metabolism<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Carcinoma, Squamous Cell--drug therapy<br/>Case-Control Studies<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Lung Diseases, Interstitial--drug therapy<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Prognosis<br/>Stromal Cells--metabolism<br/>Survival Rate